Volume 22 Issue 11
Nov.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(11): 1971-1975
MA Yunyun, JIANG Zijuan, LI Ping, WANG Xiaoxiao, ZHANG Luoluo. Research hotspot of moyamoya disease: a visualized analysis based on CiteSpace software[J]. Chinese Journal of General Practice, 2024, 22(11): 1971-1975. doi: 10.16766/j.cnki.issn.1674-4152.003777
Citation: MA Yunyun, JIANG Zijuan, LI Ping, WANG Xiaoxiao, ZHANG Luoluo. Research hotspot of moyamoya disease: a visualized analysis based on CiteSpace software[J]. Chinese Journal of General Practice, 2024, 22(11): 1971-1975. doi: 10.16766/j.cnki.issn.1674-4152.003777
shu

Research hotspot of moyamoya disease: a visualized analysis based on CiteSpace software

doi: 10.16766/j.cnki.issn.1674-4152.003777
  • 1.

    Cerebrovascular Disease Center, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210029, China

Funds:

 H2023143

 YKK22136

 NMUB20230191

  • Received Date: 2024-04-25
    Available Online: 2024-12-31
    Abstract
  •   Objective  To search and visually analyze the literature related to moyamoya disease based on CiteSpace, and summarize the research status, research hotspot and development trend in this field, in order to provide reference for subsequent research.  Methods  The literature related to moyamoya disease in the core collection database of Web of Science from January 1, 2011 to August 21, 2023 was searched by computer. CiteSpace 6.2.R4 was used for visual analysis of various aspects including the number of publications, country/region distribution, institution distribution, author distribution, keywords, etc.  Results  A total of 2 499 articles in English were included, and the number of foreign publications on Moyamoya disease showed a slow rising trend from 2011 to 2023, mainly in Asian countries represented by China and Japan. Capital Medical University, Seoul National University and Hokkaido University were the top three institutions of the number of publications. Most of the top authors came from these institutions or countries, forming a close cooperating team. However, there is currently low intensity of cooperation around the world. At present, the research on moyamoya disease mainly focuses on its pathogenesis, improvement of surgical methods, and postoperative complications. Keyword co-occurrence analysis showed that intracranial and extracranial bypass, clinical features, and vascular disease centrality were the strongest areas. Key words clustering involved postoperative complications of revascularization such as cerebral hyperperfusion syndrome, arterial spin labeling and other examination techniques, and the pathogenesis of moyamoya disease such as ring finger protein 213. Emergent word analysis shows that spontaneous occlusion, pial angioplasty and gene are the hot topics in recent years.  Conclusion  The causes of moyamoya disease, the effects of treatment on the long-term curative effect, and the course of the disease are still puzzling clinical diagnosis and treatment. In the future, researchers can further pay attention to the pathophysiological changes in blood vessels in moyamoya disease patients and conduct case reports.

     

    • FullText(HTML)
  • loading
    • References(23)
  • [1]
    烟雾病治疗中国专家共识编写组. 烟雾病治疗中国专家共识[J]. 国际脑血管病杂志, 2019, 27(9): 645-650.

    Writing group for Chinese expert consensus statement on the diagnosis and treatment of moyamoya disease. Chinese expert consensus statement on the diagnosis and treatment of moyamoya disease[J]. International Journal of Cerebrovascular Diseases, 2019, 27(9): 645-650.
    [2]
    FUJIMURA M, TOMINAGA T, KURODA S, et al. 2021 Japanese Guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan Stroke Society[J]. Neurol Med Chir (Tokyo), 2022, 62(4): 165-170. doi: 10.2176/jns-nmc.2021-0382
    [3]
    GONZALEZ N R, AMIN-HANJANI S, BANG O Y, et al. Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association/American Stroke Association[J]. Stroke, 2023, 54(10): e465-e479.
    [4]
    SUN Y X, ZHOU G Y, FENG J N, et al. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study[J]. Stroke Vasc Neurol, 2021, 6(4): 615-623. doi: 10.1136/svn-2021-000909
    [5]
    GRAF J, SCHWITALLA J C, ALBRECHT P, et al. Misdiagnoses and delay of diagnoses in Moyamoya angiopathy: a large Caucasian case series[J]. J Neurol, 2019, 266(5): 1153-1159. doi: 10.1007/s00415-019-09245-9
    [6]
    雷霆, 张华楸, 黄逸民, 等. 烟雾病发病机制研究和诊疗进展[J]. 中华实验外科杂志, 2023, 40(9): 1698-1700.

    LEI T, ZHANG H Q, HUANG Y M, et al. Comentary on mechanical investigation and progress of therapeutic methods of Moyamoya disease[J]. Chinese Journal of Experimental Surgery, 2023, 40(9): 1698-1700.
    [7]
    IHARA M, YAMAMOTO Y, HATTORI Y, et al. Moyamoya disease: diagnosis and interventions[J]. Lancet Neurol, 2022, 21(8): 747-758. doi: 10.1016/S1474-4422(22)00165-X
    [8]
    ISHISAKA E, WATANABE A, MURAI Y, et al. Role of RNF213 polymorphism in defining quasi-Moyamoya disease and definitive moyamoya disease[J]. Neurosurg Focus, 2021, 51(3): E2. DOI: 10.3171/2021.5.FOCUS21182.
    [9]
    HIRUMA M, WATANABE N, MITSUMATSU T, et al. Clinical features of Moyamoya disease with Graves' disease: a retrospective study of 394, 422 patients with thyroid disease[J]. Endocr J, 2023, 70(2): 141-148. doi: 10.1507/endocrj.EJ22-0319
    [10]
    JEONG W, SEONG G M, OH J H, et al. A case report of critical ischemic stroke in Moyamoya-like vasculopathy accompanied by systemic lupus erythematosus[J]. Encephalitis, 2022, 2(1): 24-27. doi: 10.47936/encephalitis.2021.00150
    [11]
    BOLEM N, NGA V D W, CHOU N, et al. Coexisting Moyamoya syndrome and type 1 diabetes mellitus: a case report and review of the literature[J]. Asian J Neurosurg, 2020, 15(1): 194-197. doi: 10.4103/ajns.AJNS_218_19
    [12]
    SHANG S L, ZHOU D, YA J Y, et al. Progress in moyamoya disease[J]. Neurosurg Rev, 2020, 43(2): 371-382. doi: 10.1007/s10143-018-0994-5
    [13]
    KLEINDORFER D O, TOWFIGHI A, CHATURVEDI S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association[J]. Stroke, 2021, 52(7): e364-e467.
    [14]
    NGUYEN V N, MOTIWALA M, ELARJANI T, et al. Direct, indirect, and combined extracranial-to-intracranial bypass for adult Moyamoya disease: an updated systematic review and meta-analysis[J]. Stroke, 2022, 53(12): 3572-3582. doi: 10.1161/STROKEAHA.122.039584
    [15]
    YU J, ZHANG J B, LI J L, et al. Cerebral hyperperfusion syndrome after revascularization surgery in patients with Moyamoya disease: systematic review and meta-analysis[J]. World Neurosurg, 2020, 135: 357-366. e4. DOI: 10.1016/j.wneu.2019.11.065.
    [16]
    陈传玉, 邓克学, 邱峻, 等. 动脉自旋标记技术对缺血型和出血型烟雾病患者脑灌注情况的评估[J]. 中华全科医学, 2019, 17(12): 2001-2003, 2012. doi: 10.16766/j.cnki.issn.1674-4152.001112

    CHEN C Y, DENG K X, QIU J, et al. Evaluation of cerebral perfusion in patients with ischemic and hemorrhagic moyamoya disease by arterial spin labeling[J]. Chinese Journal of General Practice, 2019, 17(12): 2001-2003, 2012. doi: 10.16766/j.cnki.issn.1674-4152.001112
    [17]
    LIU E H, LIU C Y, JIN L D, et al. Clinical value of the systemic immune-inflammation index in Moyamoya disease[J]. Front Neurol, 2023, 14: 1123951. DOI: 10.3389/fneur.2023.1123951.
    [18]
    WANG Q N, ZOU Z X, WANG X P, et al. Endothelial Progenitor cells induce angiogenesis: a potential mechanism underlying neovascularization in encephaloduroarteriosynangiosis[J]. Transl Stroke Res, 2021, 12(2): 357-365. doi: 10.1007/s12975-020-00834-9
    [19]
    FEUGRAY G, MIRANDA S, DUCHEZ V L, et al. Endothelial progenitor cells in autoimmune disorders[J]. Stem Cell Rev Rep, 2023, 19(8): 2597-2611. doi: 10.1007/s12015-023-10617-y
    [20]
    TINELLI F, NAVA S, ARIOLI F, et al. Vascular remodeling in moyamoya angiopathy: from peripheral blood mononuclear cells to endothelial cells[J]. Int J Mol Sci, 2020, 21(16): 5763. DOI: 10.3390/ijms21165763.
    [21]
    GORLA G, GARROZZINI T, POLLACI G, et al. Increase of circulating endothelial progenitor cells and released angiogenic factors in children with Moyamoya arteriopathy[J]. Int J Mol Sci, 2023, 24(2): 1233. DOI: 10.3390/ijms24021233.
    [22]
    NAKAMURA H, SATO K, YOSHIMURA S, et al. Moyamoya disease associated with Graves' disease and down syndrome: a case report and literature review[J]. J Stroke Cerebrovasc Dis, 2021, 30(1): 105414. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105414.
    [23]
    SLINGERLAND A L, KARSTEN M B, SMITH E R, et al. Two sides of a coin: case report of unilateral synangiosis and contralateral stroke highlighting consequences of disease progression and efficacy of revascularization in sickle cell disease-associated Moyamoya syndrome[J]. Acta Haematol, 2022, 145(4): 458-464. doi: 10.1159/000521361
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (44) PDF downloads(2) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return